Active Ingredient History
Human papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either two, four, or nine types of HPV. All HPV vaccines protect against at least HPV types 16 and 18, which cause the greatest risk of cervical cancer. It is estimated that HPV vaccines may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and show more than 90% efficacy in preventing HPV-positive oropharyngeal cancers. They additionally prevent some genital warts, with the quadrivalent and nonavalent vaccines that protect against HPV types HPV-6 and HPV-11 providing greater protection. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Papillomavirus Vaccines (approved 2014)
Acquired Immunodeficiency Syndrome (Phase 3)
Adenocarcinoma in Situ (Phase 3)
Alphapapillomavirus (Phase 3)
Androgens (Phase 3)
Anus Neoplasms (Phase 3)
Carcinoma (Phase 4)
Carcinoma, Squamous Cell (Phase 3)
Cervical Intraepithelial Neoplasia (Phase 4)
Condylomata Acuminata (Phase 3)
COVID-19 (Phase 3)
Dengue (Phase 3)
Drug Evaluation (Phase 4)
Drugs, Investigational (Phase 2)
Genital Diseases (Phase 3)
Head and Neck Neoplasms (Phase 1/Phase 2)
Healthy Volunteers (Phase 3)
Hematopoietic Stem Cell Transplantation (Phase 4)
HIV (Phase 4)
HIV Infections (Phase 4)
Human papillomavirus 16 (Phase 4)
Immunization (Phase 4)
Inflammatory Bowel Diseases (Phase 4)
Lung Diseases (Early Phase 1)
Lymphoma (Phase 4)
Neoplasms (Phase 4)
Papilloma (Phase 3)
Papillomaviridae (Phase 4)
Papillomavirus Infections (Phase 4)
Papillomavirus Vaccines (Phase 4)
Penile Neoplasms (Phase 1/Phase 2)
Thrombocytopenia (Phase 2)
Transplants (Phase 3)
Uterine Cervical Dysplasia (Phase 4)
Uterine Cervical Neoplasms (Phase 4)
Vaginal Neoplasms (Phase 3)
Vulvar Neoplasms (Phase 4)
Warts (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue